Seven Grand Managers LLC Buys Shares of 645,500 Lumexa Imaging Holdings, Inc. $LMRI

Seven Grand Managers LLC purchased a new position in Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 645,500 shares of the company’s stock, valued at approximately $11,942,000. Seven Grand Managers LLC owned about 0.68% of Lumexa Imaging at the end of the most recent reporting period.

Separately, Geode Capital Management LLC acquired a new stake in shares of Lumexa Imaging in the fourth quarter worth about $1,548,000.

Insiders Place Their Bets

In other Lumexa Imaging news, Director Brett Brodnax bought 35,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 19th. The stock was purchased at an average price of $7.25 per share, for a total transaction of $253,750.00. Following the purchase, the director directly owned 62,027 shares in the company, valued at $449,695.75. This trade represents a 129.50% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.70% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on LMRI shares. Barclays reduced their price target on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday, May 20th. Raymond James Financial raised Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price target for the company in a research report on Monday, February 9th. Finally, Weiss Ratings started coverage on Lumexa Imaging in a research report on Wednesday, May 13th. They issued a “sell (e-)” rating for the company. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $16.00.

Lumexa Imaging Stock Down 5.5%

Shares of NASDAQ:LMRI opened at $7.72 on Thursday. The business has a 50-day moving average of $9.35. Lumexa Imaging Holdings, Inc. has a fifty-two week low of $6.45 and a fifty-two week high of $19.45.

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).